Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has demonstrated superiority of chemoembolization compared with embolization, and the role of chemotherapy remains unclear. This randomized trial compares the outcome of embolization using mic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology Jg. 34; H. 17; S. 2046 - 2053
Hauptverfasser:	Brown, Karen T, Do, Richard K, Gonen, Mithat, Covey, Anne M, Getrajdman, George I, Sofocleous, Constantinos T, Jarnagin, William R, D'Angelica, Michael I, Allen, Peter J, Erinjeri, Joseph P, Brody, Lynn A, O'Neill, Gerald P, Johnson, Kristian N, Garcia, Alessandra R, Beattie, Christopher, Zhao, Binsheng, Solomon, Stephen B, Schwartz, Lawrence H, DeMatteo, Ronald, Abou-Alfa, Ghassan K
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 10.06.2016
Schlagworte:	Aged Antibiotics, Antineoplastic - administration & dosage Antibiotics, Antineoplastic - adverse effects Carcinoma, Hepatocellular - blood supply Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic - adverse effects Chemoembolization, Therapeutic - methods Doxorubicin - administration & dosage Doxorubicin - adverse effects Female Humans Liver Neoplasms - blood supply Liver Neoplasms - pathology Liver Neoplasms - therapy Male Microspheres Single-Blind Method
ISSN:	1527-7755
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!